DePuy ASR Hip Recall Revision Surgery

http://depuyhiprecallsite.com/

DePuy Orthopaedics was founded 1895. It was the first commercial orthopaedics company in the U.S.
that pioneering spirit. Their long-standing commitment to innovation in patient care has helped them
become a global leader in orthopaedic devices and supplies, including hip, knee, extremity, trauma,
cement, and operating room products.

Earlier this year, it has been reported that DePuy has started pulling out their defective products. The
company had stopped selling the system in late 2009. On the 26 th of August 2010, they officially
announced the recall of their malfunctioning hip replacement systems.

The DePuy hip recall was of the ASR hip implant. It comes after the device was marketed for about six
years between 2003 and 2009. The defective hip system has been implanted in a total of about 93, 000
patients.  This hip recall affects two products by DePuy namely, the ASR Hip Resurfacing System and the
ASR XL Acetabular System. This DePuy hip recall comes after years of published reports, studies and data
indicating that the device was defective and failing in patients. The reason for this DePuy hip recall is
because of the alarming number of complaints and high revision surgery rate for the device. DePuy
statistics show that “approximately 12% of patients who had received the ASR resurfacing device and
13% of patients who had received the ASR total hip replacement needed to have a revision surgery.”

After this cliff-hanger, DePuy Orthopedics issued for a hip recall revision. This means that affected
patients will undergo a painful and unnecessary DePuy hip recall revision surgery.  Of course, this
problem should have been fixed with the initial surgery if not for the defective DePuy hip.

In addition, DePuy recommends yearly monitoring "to ensure the ASR hip replacement is functioning
well, even in the absence of symptoms."
However, DePuy stated in the release that few of these devices remain on the worldwide market due to
its decision last year to discontinue the ASR system as a result of declining demand and other factors.

President of DePuy Orthopaedics Inc. also stated in the release that they are committed to assisting
patients and health care providers by providing information through multiple channels and paying for
the cost of doctor visits, tests and procedures associated with the hip recall revision.